Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
NCT05574517

Tubeless Percutaneous Nephrolithotomy Without Reverse Insertion of a Ureteral Catheter

Led by The First Affiliated Hospital of University of South China · Updated on 2024-09-24

200

Participants Needed

1

Research Sites

116 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Percutaneous nephrolithotomy(PCNL) is a surgical method for upper urinary calculi. The advent of tubeless PCNL (without indwelling nephrostomy tube) has been proved to be safe and effective in reducing postoperative discomfort, shortening hospitalization time and reducing hospitalization costs. Traditional tubeless PCNL usually involves retrograde insertion of the ureteral catheter, which may cause many ureteral related surgical complications. However, there are few reports on tubeless PCNL without reverse ureteral catheter insertion. The goal of this study is to explore the safety and effectiveness of the tubeless PCNL without reverse ureteral catheter insertion.

CONDITIONS

Official Title

Tubeless Percutaneous Nephrolithotomy Without Reverse Insertion of a Ureteral Catheter

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants who meet the 2019 Chinese Guidelines for PCNL surgery
  • Participants who agree to undergo tubeless PCNL
  • Kidney stone maximum diameter less than 3.5 cm
Not Eligible

You will not qualify if you...

  • Infectious or complex staghorn stones shown by CT or blood tests
  • Severe heart or lung failure or abnormal blood clotting
  • Previous PCNL or nephrolithotomy surgery
  • Existing ureteral stent or nephrostomy tube before surgery
  • Kidney trauma or congenital urinary system malformations

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

The First Affiliated Hospital of University of South China

Hengyang, Hunan, China, 421001

Actively Recruiting

Loading map...

Research Team

M

Mingyong Li, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here